Dexferrum is a drug owned by American Regent Inc. It is protected by 1 US drug patent filed in 2013 out of which all have expired. Based on its patents and exclusivities, its generic launch date is estimated to be Sep 29, 2015. Details of Dexferrum's patents and their expiration are given in the table below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| These drug patents focus on the other aspects of the drug like dosage, mode of administration (oral, tablet, capsules, liquids etc). | |||
| US5624668 | Iron dextran formulations |
Sep, 2015
(9 years ago) |
Expired
|
US patents provide insights into the exclusivity only within the United States, but Dexferrum is protected by patents in multiple countries. Understanding the full scope of patent protection is crucial in strategizing market entry. By looking at the broader patent landscape, you can identify markets with weaker patent protection which could be ideal generic entry points. The following section offers details on Dexferrum's family patents as well as insights into ongoing legal events on those patents.
Dexferrum's Family Patents
Explore Our Curated Drug Screens
Generic Launch
Generic Release Date:
Dexferrum's generic launch date based on the expiry of its last outstanding patent is estimated to be Sep 29, 2015 (This date is subject to change depending upon the patent filing activities by the drug owner or exclusivity additions to its drug application)
Dexferrum Generic API suppliers:
Ferric Oxyhydroxide is the generic name for the brand Dexferrum. 1 company has already filed for the generic of Dexferrum. Check out the entire list of companies who have already received approval for Dexferrum's generic
Alternative Brands for Dexferrum
There are several other brand drugs using the same active ingredient (Ferric Oxyhydroxide) as Dexferrum. Given below is the list of those companies and their brand drugs, to help you identify new opportunities, assess competitors, and plan your market strategies more effectively.
| Drug Owner | Drug Name | |
|---|---|---|
| Vifor Fresenius |
|
Apart from brand drugs containing the same ingredient, some generics have also been filed for Ferric Oxyhydroxide, Dexferrum's active ingredient. Check the complete list of approved generic manufacturers for Dexferrum
About Dexferrum
Dexferrum is a drug owned by American Regent Inc. Dexferrum uses Ferric Oxyhydroxide as an active ingredient. Dexferrum was launched by Am Regent in 1996.
Approval Date:
Dexferrum was approved by FDA for market use on 23 February, 1996.
Active Ingredient:
Dexferrum uses Ferric Oxyhydroxide as the active ingredient. Check out other Drugs and Companies using Ferric Oxyhydroxide ingredient
Dosage:
Dexferrum is available in injectable form for injection use. Given below is detailed information on Dosage -
| Strength | Dosage Form | Availability | Application Pathway |
|---|---|---|---|
| EQ 50MG IRON/ML | INJECTABLE | Discontinued | INJECTION |